Advanced Molecular Detection (AMD) and Response to Infectious Disease Outbreaks

Related Pages

Advanced molecular detection (AMD) integrates the latest next-generation genomic sequencing technologies with bioinformatics and epidemiology expertise across CDC and the nation to help us find, track, and stop disease-causing pathogens faster than ever before.

Two lab scientists preparing vials for sequencing using a large machine
Who We Are
Scientist identifying pathogens on a computer screen.
What We Do
Closeup of a flow cell for an Illumina sequencing machine held by hands in blue gloves. The scientist's face can be seen in the background.
What's New
A scientist working with samples in a lab.
How it Works
What's New
CDC awards nearly $9 million for SARS-CoV-2 Sequencing

Posted on Tuesday, November 17, 2020

The Centers for Disease Control and Prevention (CDC) awarded nearly $9 million through a broad agency announcement (BAA) in fiscal year (FY) 2020 to support the SARS-CoV-2 Sequencing for Public Health Emergency Response, Epidemiology and Surveillance (SPHERES) initiative. These projects will help fill gaps in knowledge and grow the agency’s innovative approaches to respond to the COVID-19 pandemic. SPHERES builds upon the 6 years of investments from the CDC Advanced Molecular Detection (AMD) program which integrates the latest next-generation genomic sequencing technologies with bioinformatics and epidemiology expertise across CDC and the nation.

Learn more on our What's New page
Resources
illustration of PulseNet scientists with a background that symbolizes the transition from PFGE technology to whole genome sequencing technology
Follow us @CDC_AMD
Related Links

Page last reviewed: November 17, 2020
Content source: Centers for Disease Control and Prevention